Related Experiment Video
Updated: Apr 17, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Status migrainosus as an initial presentation of multiple sclerosis.
Raed Alroughani1, Samar F Ahmed2, Riyadh Khan3
1Division of Neurology, Department of Medicine, Amiri Hospital, Arabian Gulf Street, Sharq, 13041 Kuwait ; Neurology Clinic, Department of Medicine, Dasman Diabetes Institute, P.O. Box 1180, Dasman, 15462 Kuwait.
Status migrainosus, a severe migraine, can be an early sign of multiple sclerosis (MS). Persistent headaches unresponsive to typical migraine treatments may indicate underlying demyelinating disease.
Area of Science:
- Neurology
- Neuroimmunology
Background:
- Headache, particularly status migrainosus, can arise from demyelinating plaques disrupting neural pathways involved in migraine pathogenesis.
- A case study of a 25-year-old female presenting with status migrainosus is detailed, who was later diagnosed with multiple sclerosis (MS).
Purpose of the Study:
- To highlight status migrainosus as a potential initial presentation of multiple sclerosis.
- To emphasize the diagnostic challenges posed by unresponsive migraine symptoms in the context of active demyelination.
Main Methods:
- Clinical presentation of status migrainosus.
- Magnetic resonance imaging (MRI) for detecting demyelinating lesions.
- Diagnostic criteria for multiple sclerosis (revised 2010 McDonald criteria).
- Treatment response to migraine prophylactic and abortive therapies, IV methylprednisolone, and disease-modifying therapy.
Main Results:
- Initial MRI showed demyelinating lesions; patient was unresponsive to migraine prophylactic treatment.
- Follow-up MRI revealed multiple gadolinium-enhancing lesions, and the patient developed neurological symptoms (paresthesia, weakness).
- Diagnosis of MS was confirmed; symptoms improved with methylprednisolone and disease-modifying therapy, leading to headache remission.
Conclusions:
- Status migrainosus can be the first clinical manifestation of multiple sclerosis.
- Lack of response to migraine therapy coupled with active demyelinating plaques on MRI warrants consideration of MS diagnosis.
Related Concept Videos
Multiple Sclerosis l: Introduction
Arboviral Encephalitis
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis ll: Pathophysiology
Bacterial Meningitis I: Introduction
Equilibrium and Balance

